NCMP-37. Clinical patterns and long-term outcomes in stroke-like migraine attacks after radiation therapy (SMART): a case series
Abstract
Stroke-like migraine attacks after radiation therapy (SMART) syndrome is a rare and underrecognized complication of prior cranial irradiation. It is characterized by recurrent migraine-like headaches temporally associated with neurological deficits, including visual disturbance, aphasia and weakness, and seizure activity. MRI brain classically demonstrates unilateral cortical gyriform or ribbon enhancement with corresponding T2/FLAIR changes in previously irradiated regions without clear diffusion restriction or susceptibility changes. MRI changes are transient and may not be found in every attack. Many patients experience clinical recovery with supportive care, accompanied by corresponding radiographic improvement. Recurrent episodes are common though the true incidence and frequency remain to be elucidated. The role of supportive therapy in preventing recurrences is also unclear. Corticosteroids, aspirin, calcium channel blockers and valproate have been suggested as supportive therapy based on a hypothesis of radiation-induced vascular dysfunction. We present a single-institution case series of 6 patients with long term observation of SMART syndrome, consisting of 4 women and 2 men, who received brain radiation between the ages of 12 and 59 for malignant gliomas (3), germ cell tumor (1), atypical meningioma (1) and choroid plexus carcinoma (1). They presented with abrupt onset of SMART syndrome with a range of 6 to 26 (mean 14.5) years after radiation. Recurrence of SMART…
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health. Reported size: 6 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.